Evaluation of endostatin antiangiogenesis gene therapy in vitro and in vivo

Cancer Gene Therapy

Volumn 8, Issue 12, 2001, Pages 982-989

  Jin, Xiaomei ^a   Bookstein, Rob ^a   Wills, Ken ^a   Avanzini, Jenny ^a   Tsai, Van ^a   LaFace, Drake ^a   Terracina, Gaby ^a   Shi, Bin ^a   Nielsen, Loretta L ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Antiangiogenesis; Endostatin; Gene therapy; Recombinant adenovirus

Indexed keywords

ALKALINE PHOSPHATASE; ANGIOGENESIS INHIBITOR; BASIC FIBROBLAST GROWTH FACTOR; ENDOSTATIN; VIRUS ANTIBODY; VIRUS VECTOR;

ADENOVIRUS; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BREAST TUMOR; CANCER GROWTH; CELL CULTURE; CELL MIGRATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; ENDOTHELIUM CELL; FEMALE; GENE THERAPY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MITOSIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; SUPERNATANT; TUMOR CELL LINE; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANGIOGENESIS INHIBITORS; ANIMALS; CELLS, CULTURED; COLLAGEN; COLLAGEN TYPE XVIII; ENDOSTATINS; ENDOTHELIUM, VASCULAR; GENE THERAPY; GENETIC VECTORS; HUMANS; MICE; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDE FRAGMENTS; REASSORTANT VIRUSES;

ADENOVIRIDAE; ANIMALIA;

EID: 0035214022     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700396     Document Type: Article

References (26)

1. Blood vessel formation: What is its molecular basis?
2. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
3. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
4. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
5. Derivation and initial characterization of a mouse mammary tumor cell line carrying the polyomavirus middle T antigen: Utility in the development of novel cancer therapeutics
6. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli
7. Purification of a type 5 recombinant adenovirus encoding human p53 by column chromatography
8. Analytical anion exchange HPLC of recombinant type-5 adenoviral particles
9. The polypeptides of adenovirus: 1. Evidence for multiple protein components in the virion and a comparison of types 2, 7a, and 12
10. Comparison of flow cytometry and laser scanning cytometry for the intracellular evaluation of adenoviral infectivity and p53 protein expression in gene therapy
11. Extracellular matrix regulation of multidrug resistance in primary monolayer cultures of adult rat hepatocytes
12. In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses
13. Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer
14. Endostatin induces endothelial cell apoptosis
15. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice
16. Crystal structure of the angiogenesis inhibitor endostatin at 1.5 Å resolution
17. Endostatin: Yeast production, mutants, and antitumor effect in renal cell carcinoma
18. Cloning, expression, and in vitro activity of human endostatin
19. Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding
20. Zinc-binding of endostatin is essential for its antiangiogenic activity
21. Regional suppression of tumor growth by in vivo transfer of a cDNA encoding a secreted form of the extracellular domain of the flt-1 vascular endothelial growth factor receptor
22. Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2
23. Adeno-virus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases
24. Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice
25. Antiangiogenic gene therapy of cancer utilizing a recombinant adenovirus to elevate systemic endostatin levels in mice
26. Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene